Looks like Fibrobiologics has lots of products using fibroblasts in regenerative medicine  already in the pipeline and from what I can see the one for MS looks the most advanced. It looks like it went through a first phase and is now ready for a second phase. Some other diseases that are being addressed look like they are in the discovery and preclinical stages. A treatment for MS alone would give this company a whole lot of credibility, and they have a number of others related to everything from disc disease to cancer to diabetic wound care. Off topic maybe, but as I said before, it could not hurt LBSR if Fibrobiologics continues on its promising path to treating all these diseases/conditions.